Redefining Care With Precision Diagnostics

OncoHelix is a global leader in advanced molecular and immune diagnostics, boasting an exceptional background in precision oncology and a growing portfolio of wellness and reproductive health tests.

OncoHelix has partnered with the Hematology Translational Lab (HTL) at the University of Calgary, forming one of the largest clinically accredited lab diagnostics providers in Western Canada.

OncoHelix also operates the state-of-the-art OncoHelix-coLAB in partnership with Burjeel Holdings in Abu Dhabi, bringing cutting-edge diagnostic solutions closer to patients in the UAE and broader MENA region.

OncoHelix delivers reliable and personalized insights — Better Insights. Better Health.

Meet the Team

  • Dr. Faisal Masood Khan

    Chief Executive Officer

  • Dr. Pinaki Bose

    Executive Vice-President

  • Dr. Meer-Taher Shabani-Rad

    Vice-President, Medical Affairs

  • Dr. Christopher Naugler

    Medical Director

  • Dr. Poonal Dharmani-Khan

    Director, Cellular and Immune Diagnostics

  • Dr. Rehan Mujeeb Faridi

    Director, Molecular Diagnostics

  • Kevin James

    Director, Strategic Partnerships

  • Kalpita Reddiar

    Business Development Associate

Collaborative Excellence Through Partnerships

Diagnostic Partner

Provincial Health Authorities/Advocacy Groups

Clinical Trial Partner

Pharmaceuticals & BioTechs

Translational Research Partner

Cancer Centers & Genomic/Immunology

Our Partners/Clients